Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul C Adams

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Hepato-Biliary-Pancreatic Sciences|October 15, 2013
Female donor to male recipient gender discordance results in inferior graft survival: a prospective study of 1,042 liver transplantsKristopher P Croome, Dan Segal, Roberto Hernandez-Alejandro, et al.
The Journal of Laboratory and Clinical Medicine|June 25, 2002
A nomogram to predict C282Y hemochromatosisJerry S McGrath, Yves Deugnier, Romain Moirand, et al.
Nature Reviews. Disease Primers|April 6, 2018
HaemochromatosisPierre Brissot, Antonello Pietrangelo, Paul C Adams, et al.
Hepatology (Baltimore, Md.)|April 1, 2011
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver DiseasesBruce R Bacon, Paul C Adams, Kris V Kowdley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2012
Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosisJames C Barton, J Clayborn Barton, Ronald T Acton, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2013
HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/LPaul C Adams, Christine E McLaren, Mark Speechley, et al.
Transplantation|June 26, 2007
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acidNimer Assy, Paul C Adams, Paul Myers, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening studyPaul C Adams, Mark Speechley, James C Barton, et al.
Thyroid : Official Journal of the American Thyroid Association|July 25, 2008
Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS studyJames C Barton, Catherine Leiendecker-Foster, David M Reboussin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 3, 2008
HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) StudyJames S Pankow, Eric Boerwinkle, Paul C Adams, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Hepato-Biliary-Pancreatic Sciences|October 15, 2013
Female donor to male recipient gender discordance results in inferior graft survival: a prospective study of 1,042 liver transplantsKristopher P Croome, Dan Segal, Roberto Hernandez-Alejandro, et al.
The Journal of Laboratory and Clinical Medicine|June 25, 2002
A nomogram to predict C282Y hemochromatosisJerry S McGrath, Yves Deugnier, Romain Moirand, et al.
Nature Reviews. Disease Primers|April 6, 2018
HaemochromatosisPierre Brissot, Antonello Pietrangelo, Paul C Adams, et al.
Hepatology (Baltimore, Md.)|April 1, 2011
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver DiseasesBruce R Bacon, Paul C Adams, Kris V Kowdley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2012
Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosisJames C Barton, J Clayborn Barton, Ronald T Acton, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2013
HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/LPaul C Adams, Christine E McLaren, Mark Speechley, et al.
Transplantation|June 26, 2007
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acidNimer Assy, Paul C Adams, Paul Myers, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening studyPaul C Adams, Mark Speechley, James C Barton, et al.
Thyroid : Official Journal of the American Thyroid Association|July 25, 2008
Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS studyJames C Barton, Catherine Leiendecker-Foster, David M Reboussin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 3, 2008
HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) StudyJames S Pankow, Eric Boerwinkle, Paul C Adams, et al.
Pageof 13